XORTX Therapeutics Inc. (XRTX) concluded trading on 01/19/23 at a closing price of $0.87, with 43.63 million shares of worth about $37.96 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -40.82% during that period and on Thursday the price saw a gain of about 11.14%. Currently the company’s common shares owned by public are about 12.99M shares, out of which, 12.83M shares are available for trading.
A deeper look into what the analysts at Wall Street are thinking about the price target of this stock provides us with the following: 1 analysts are covering the XRTX stock and their offered price forecasts bring an average price target of $9.00. Over the next 12 months, analysts forecasted that the stock’s price could jump as high as $9.00 and could fall to a lowest price of $9.00. However, touching the estimated high of $9.00 would mean a gain of 90.33% for the stock.
Will You Miss Out On This Growth Stock Boom?
A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.
And this is just one of our
5 Best Growth Stocks To Own For 2023.
Sponsored
XORTX Therapeutics Inc. (NASDAQ: XRTX) started trading at $1.08, above $0.3 from concluding price of the previous day. However, the stock later moved at a day high price of 1.2400, or with a gain of 11.14%. Stock saw a price change of 12.96% in past 5 days and over the past one month there was a price change of 6.81%. Year-to-date (YTD), XRTX shares are showing a performance of 7.67% which decreased to -52.97% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.66 but also hit the highest price of $2.48 during that period. The average intraday trading volume for XORTX Therapeutics Inc. shares is 23.57K. The stock is currently trading 9.04% above its 20-day simple moving average (SMA20), while that difference is up 4.07% for SMA50 and it goes to -30.37% lower than SMA200.
XORTX Therapeutics Inc. (NASDAQ: XRTX) currently have 12.99M outstanding shares and institutions hold larger chunk of about 6.67% of that. Holding of mutual funds in the company is about — while other institutional holders and individual stake holders have control over — and — of the stake respectively.
The stock has a current market capitalization of $18.96M and its 3Y-monthly beta is at 0.31. PE ratio of stock for trailing 12 months is 3.78, while it has posted earnings per share of $0.23 in the same period. It has Quick Ratio of 6.50 while making debt-to-equity ratio of 0.01. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for XRTX, volatility over the week remained 18.93% while standing at 14.43% over the month.
Analysts are in expectations that XORTX Therapeutics Inc. (XRTX) stock would likely to be making an EPS of $0 in the current quarter, while forecast for next quarter EPS is $0 and it is $0 for next year. For the current quarter EPS, analysts have given the company a lowest target $0 which is $0 at the higher side of the target for the same. Stock’s fiscal year EPS is expected to rise by 13.00% while it is estimated to increase by 11.30% in next year.
Analysts at 1 brokerage firms have issued recommendations for the XORTX Therapeutics Inc. (XRTX)’s stock and average of those rates the stock at a “Moderate Buy” and assign it a score of 2.00. Out of those 1 Wall Street analysts, 1 recommended a “Buy” rating, while 0 were in favor recommending the stock as a “Hold” and 0 analyst recommended the stock as “Sell”.
